Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure
Nicolas W Shammas,1,2 Gail A Shammas,1 Susan Jones-Miller,1,2 Mileah Rose Gumpert,1 Miranda Jade Gumpert,1 Christine Harb,1 Majid Z Chammas,1 W John Shammas,1 Rommy A Khalafallah,1 Amy Barzgari,1 Bassel Bou Dargham,1 Ghassan E Daher,1 Rayan Jo Rachwan,1 Andrew N Shammas1 1Midwest Cardiovascular Res...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ed3559ea127342dcaeac0d716a8c1f00 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ed3559ea127342dcaeac0d716a8c1f00 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ed3559ea127342dcaeac0d716a8c1f002021-12-02T11:02:47ZPredictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure1178-203Xhttps://doaj.org/article/ed3559ea127342dcaeac0d716a8c1f002017-03-01T00:00:00Zhttps://www.dovepress.com/predictors-of-common-femoral-artery-access-site-complications-in-patie-peer-reviewed-article-TCRMhttps://doaj.org/toc/1178-203XNicolas W Shammas,1,2 Gail A Shammas,1 Susan Jones-Miller,1,2 Mileah Rose Gumpert,1 Miranda Jade Gumpert,1 Christine Harb,1 Majid Z Chammas,1 W John Shammas,1 Rommy A Khalafallah,1 Amy Barzgari,1 Bassel Bou Dargham,1 Ghassan E Daher,1 Rayan Jo Rachwan,1 Andrew N Shammas1 1Midwest Cardiovascular Research Foundation, 2Cardiology Division, Genesis Heart Institute, Davenport, IA, USA Background: It is unclear whether patients on oral anticoagulants (OAC) undergoing a procedure using common femoral artery access have higher adverse events when compared to patients who are not anticoagulated at the time of the procedure.Methods: We retrospectively reviewed data from consecutive patients who underwent a cardiac procedure at a tertiary medical center. Patients were considered (group A) fully or partially anticoagulated if they had an international normalized ratio (INR) ≥1.6 on the day of the procedure or were on warfarin or new OAC within 48 h and 24 h of the procedure, respectively. The nonanticoagulated group (group B) had an INR <1.6 or had stopped their warfarin and new OAC >48 h and >24 h preprocedure, respectively. The index primary end point of the study was defined as the composite end point of major bleeding, vascular complications, or cardiovascular-related death during index hospitalization. The 30-day primary end point was defined as the occurrence of the index primary end point and up to 30 days postprocedure.Results: A total of 779 patients were included in this study. Of these patients, 27 (3.5%) patients were in group A. The index primary end point was met in 11/779 (1.4%) patients. The 30-day primary composite end point was met in 18/779 (2.3%) patients. There was no difference in the primary end point at index between group A (1/27 [3.7%]) and group B (10/752 [1.3%]; P=0.3155) and no difference in the 30-day primary composite end point between group A (2/27 [7.4%]) and group B (16/752 [2.1%]; P=0.1313). Multivariable analysis showed that a low creatinine clearance (odds ratio [OR] =0.56; P=0.0200) and underweight patients (<60 kg; OR =3.94; P=0.0300) were independent predictors of the 30-day primary composite end point but not oral anticoagulation (P=0.1500).Conclusion: Patients on OAC did not have higher 30-day major adverse events than those who were not anticoagulated at index procedure. Keywords: access site, common femoral artery, complications, oral anticoagulantShammas NWShammas GAJones-Miller SGumpert MRGumpert MJHarb CChammas MZShammas WJKhalafallah RABarzgari ABou Dargham BDaher GERachwan RJShammas ANDove Medical PressarticleAccess siteCommon Femoral ArteryComplicationsOral anticoagulantTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 13, Pp 401-406 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Access site Common Femoral Artery Complications Oral anticoagulant Therapeutics. Pharmacology RM1-950 |
spellingShingle |
Access site Common Femoral Artery Complications Oral anticoagulant Therapeutics. Pharmacology RM1-950 Shammas NW Shammas GA Jones-Miller S Gumpert MR Gumpert MJ Harb C Chammas MZ Shammas WJ Khalafallah RA Barzgari A Bou Dargham B Daher GE Rachwan RJ Shammas AN Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
description |
Nicolas W Shammas,1,2 Gail A Shammas,1 Susan Jones-Miller,1,2 Mileah Rose Gumpert,1 Miranda Jade Gumpert,1 Christine Harb,1 Majid Z Chammas,1 W John Shammas,1 Rommy A Khalafallah,1 Amy Barzgari,1 Bassel Bou Dargham,1 Ghassan E Daher,1 Rayan Jo Rachwan,1 Andrew N Shammas1 1Midwest Cardiovascular Research Foundation, 2Cardiology Division, Genesis Heart Institute, Davenport, IA, USA Background: It is unclear whether patients on oral anticoagulants (OAC) undergoing a procedure using common femoral artery access have higher adverse events when compared to patients who are not anticoagulated at the time of the procedure.Methods: We retrospectively reviewed data from consecutive patients who underwent a cardiac procedure at a tertiary medical center. Patients were considered (group A) fully or partially anticoagulated if they had an international normalized ratio (INR) ≥1.6 on the day of the procedure or were on warfarin or new OAC within 48 h and 24 h of the procedure, respectively. The nonanticoagulated group (group B) had an INR <1.6 or had stopped their warfarin and new OAC >48 h and >24 h preprocedure, respectively. The index primary end point of the study was defined as the composite end point of major bleeding, vascular complications, or cardiovascular-related death during index hospitalization. The 30-day primary end point was defined as the occurrence of the index primary end point and up to 30 days postprocedure.Results: A total of 779 patients were included in this study. Of these patients, 27 (3.5%) patients were in group A. The index primary end point was met in 11/779 (1.4%) patients. The 30-day primary composite end point was met in 18/779 (2.3%) patients. There was no difference in the primary end point at index between group A (1/27 [3.7%]) and group B (10/752 [1.3%]; P=0.3155) and no difference in the 30-day primary composite end point between group A (2/27 [7.4%]) and group B (16/752 [2.1%]; P=0.1313). Multivariable analysis showed that a low creatinine clearance (odds ratio [OR] =0.56; P=0.0200) and underweight patients (<60 kg; OR =3.94; P=0.0300) were independent predictors of the 30-day primary composite end point but not oral anticoagulation (P=0.1500).Conclusion: Patients on OAC did not have higher 30-day major adverse events than those who were not anticoagulated at index procedure. Keywords: access site, common femoral artery, complications, oral anticoagulant |
format |
article |
author |
Shammas NW Shammas GA Jones-Miller S Gumpert MR Gumpert MJ Harb C Chammas MZ Shammas WJ Khalafallah RA Barzgari A Bou Dargham B Daher GE Rachwan RJ Shammas AN |
author_facet |
Shammas NW Shammas GA Jones-Miller S Gumpert MR Gumpert MJ Harb C Chammas MZ Shammas WJ Khalafallah RA Barzgari A Bou Dargham B Daher GE Rachwan RJ Shammas AN |
author_sort |
Shammas NW |
title |
Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
title_short |
Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
title_full |
Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
title_fullStr |
Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
title_full_unstemmed |
Predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
title_sort |
predictors of common femoral artery access site complications in patients on oral anticoagulants and undergoing a coronary procedure |
publisher |
Dove Medical Press |
publishDate |
2017 |
url |
https://doaj.org/article/ed3559ea127342dcaeac0d716a8c1f00 |
work_keys_str_mv |
AT shammasnw predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT shammasga predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT jonesmillers predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT gumpertmr predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT gumpertmj predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT harbc predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT chammasmz predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT shammaswj predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT khalafallahra predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT barzgaria predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT boudarghamb predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT daherge predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT rachwanrj predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure AT shammasan predictorsofcommonfemoralarteryaccesssitecomplicationsinpatientsonoralanticoagulantsandundergoingacoronaryprocedure |
_version_ |
1718396327688142848 |